C4 Therapeutics at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

C4 Therapeutics takes part in 3 sessions at TPD Summit 2026 in Boston. It opens the plenary session on turning induced proximity science into clinically transformative therapies and joins a panel on the trends shaping the field. Its own talk covers DNA-encoded library screening that finds molecular glue hits for high-value targets.

OrganizationTPD Summit 2026 Attendance
C4 Therapeutics
Watertown, MA
Biotech
Clinical-stage biotech developing small-molecule targeted protein degraders for cancer.
Chair
Tue Oct 27
8:20am
Part of Defining the Future of Induced Proximity & Translating Scientific Innovation Into Clinically Transformative Therapies for Patients with Unmet Medical Need
Chair’s Opening Remarks
Plenary
Investment, partnering & strategy
Panel
Tue Oct 27
9:00am
Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact
Plenary · with Nurix Therapeutics, Foghorn Therapeutics, Stablix +1 more
Investment, partnering & strategy
Talk
Thu Oct 29
11:45am
Molecular Glue DEL Screening to Produce Expansive Datasets for Systematic Hit Identification for High Value Therapeutic Targets
Latest Tools & Technologies Track
Screening, assays & proteomics

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from C4 Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction